Skip to main content
Signal8

Liminatus Pharma Announces Nasdaq Delisting Notification

$LIMNPress releaseMay 21, 2026, 8:28 PM ET

Liminatus Pharma received a formal delisting notice from Nasdaq after failing to regain compliance with market value listing rules by the May 18, 2026 deadline. The company failed to meet the $50 million market value of listed securities and $15 million market value of publicly held shares requirements.

Key figures

Appeal deadline
May 27, 2026
Suspension date
May 29, 2026
Mvls requirement
$50,000,000
Mvphs requirement
$15,000,000
Compliance deadline
May 18, 2026

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    LIMN: Liminatus Pharma Announces Nasdaq Delisting Notification — AI Analysis | Signal8